vimarsana.com
Home
Live Updates
Roche To Buy Good Therapeutics Conditionally Active PD-1-reg
Roche To Buy Good Therapeutics Conditionally Active PD-1-reg
Roche To Buy Good Therapeutics Conditionally Active PD-1-regulated IL-2 Program
SOUTH SAN FRANCISCO (dpa-AFX) - Good Therapeutics Wednesday said Roche Holding AG (RHHBY) has agreed to acquire Good Therapeutics' conditionally active PD-1-regulated IL-2 Program.The deal also
Related Keywords
James Sabry ,
Roche Holding ,
Therapeutics Wednesday ,
Good Therapeutic ,
Good Therapeutics ,
Global Head ,
Pharma Partnering ,
Roche ,
Wood ,
Herapeutics ,
Nconditionally ,
Ctive ,
Egulated ,
Program ,